UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 30, 2025 4:00 P.M.
Form:
F-3
CIK:
0001885827
Company Name:
Virax Biolabs Group Ltd
File Number:
333-292241